Literature DB >> 25925350

Ratio of progesterone-to-number of follicles as a prognostic tool for in vitro fertilization cycles.

Matheus Roque1, Marcello Valle, Marcos Sampaio, Selmo Geber, Miguel Angel Checa.   

Abstract

PURPOSE: To establish a ratio of the P level to the number of follicles (P/F ratio) on the day of human chorionic gonadotropin (hCG) administration and to evaluate whether this ratio is associated with in vitro fertilization (IVF) outcome.
METHODS: This study was conducted between January 2012 and June 2013. A total of 337 patients with cleavage-stage day-3 fresh embryo transfer with P levels ≤1.5 ng/mL on the day of hCG administration were included in the study. The main outcome was ongoing pregnancy rate. RESULT(S): The P/F ratio was calculated according to the equation (P[ng/mL]/number of follicles) on the day of final oocyte maturation. Using ROC, we established a cut-off level of 0.075 for the P/F ratio. The area under the curve (AUC) (0.756; 95 % confidence interval [CI]: 0.704-0.807) indicated that it was a good prognostic test. In group 1 (patients under 36 years old), the ongoing pregnancy rates were 57 and 30 % for patients with P/F ratios ≤ .075 and > .075, respectively, (p = 0.003). In group 2 (patients between 36 and 39 years old), the ongoing pregnancy rates were 58 % and 17 % (p = 0.001) for patients with P/F ratios ≤ .075 and > .075, respectively. In group 3 (patients ≥ 40 years old), the ongoing pregnancy rates were 41.7 and 10.9 % (p = 0.001) for patients with P/F ratios ≤ .075 and > .075, respectively.
CONCLUSIONS: The P/F ratio is a good prognostic test for predicting IVF outcome that can correlate the P level with ovarian response.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25925350      PMCID: PMC4491074          DOI: 10.1007/s10815-015-0487-1

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  28 in total

1.  Elective frozen replacement cycles for all: ready for prime time?

Authors:  A Maheshwari; S Bhattacharya
Journal:  Hum Reprod       Date:  2012-11-11       Impact factor: 6.918

Review 2.  Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer.

Authors:  Bruce S Shapiro; Said T Daneshmand; Forest C Garner; Martha Aguirre; Cynthia Hudson
Journal:  Fertil Steril       Date:  2014-05-17       Impact factor: 7.329

3.  The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China.

Authors:  Jingjuan Ji; Yusheng Liu; Xian Hong Tong; Lihua Luo; Jinlong Ma; Zijiang Chen
Journal:  Hum Reprod       Date:  2013-07-25       Impact factor: 6.918

Review 4.  Neonatal outcomes among singleton births after blastocyst versus cleavage stage embryo transfer: a systematic review and meta-analysis.

Authors:  S Dar; T Lazer; P S Shah; C L Librach
Journal:  Hum Reprod Update       Date:  2014-01-30       Impact factor: 15.610

5.  Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles.

Authors:  C A Venetis; E M Kolibianakis; J K Bosdou; B C Tarlatzis
Journal:  Hum Reprod Update       Date:  2013-07-04       Impact factor: 15.610

6.  Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy.

Authors:  Eman A Elgindy
Journal:  Fertil Steril       Date:  2011-02-16       Impact factor: 7.329

7.  Introduction: are we ready to eliminate the transfer of fresh embryos in in vitro fertilization?

Authors:  Kurt T Barnhart
Journal:  Fertil Steril       Date:  2014-06-02       Impact factor: 7.329

8.  The value of the progesterone-to-estradiol ratio on the day of hCG administration in predicting ongoing pregnancy and live birth rates in normoresponders undergoing GnRH antagonist cycles.

Authors:  Esra S Cetinkaya; Bulent Berker; Rusen Aytac; Cem Atabekoglu; Murat Sonmezer; Batuhan Ozmen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-08-07       Impact factor: 2.435

9.  Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials.

Authors:  Georg Griesinger; Bernadette Mannaerts; Claus Yding Andersen; Han Witjes; Efstratios M Kolibianakis; Keith Gordon
Journal:  Fertil Steril       Date:  2013-09-29       Impact factor: 7.329

10.  Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE.

Authors:  A P Ferraretti; V Goossens; M Kupka; S Bhattacharya; J de Mouzon; J A Castilla; K Erb; V Korsak; A Nyboe Andersen
Journal:  Hum Reprod       Date:  2013-07-09       Impact factor: 6.918

View more
  3 in total

1.  Revisiting the progesterone to oocyte ratio.

Authors:  Micah J Hill; Mae Wu Healy; Kevin S Richter; Eric Widra; Eric D Levens; Alan H DeCherney; George Patounakis; Brian W Whitcomb
Journal:  Fertil Steril       Date:  2017-01-06       Impact factor: 7.329

Review 2.  Adverse effect of prematurely elevated progesterone in in vitro fertilization cycles: a literature review.

Authors:  Michael B Evans; Mae W Healy; Alan H DeCherney; Micah J Hill
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

3.  Are extremely high progesterone levels still an issue in IVF?

Authors:  V S Vanni; P Viganò; L Quaranta; L Pagliardini; P Giardina; M Molgora; M Munaretto; M Candiani; E Papaleo
Journal:  J Endocrinol Invest       Date:  2016-08-27       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.